Adapted treatment for paediatric tuberculosis

>Visit project page


Children suffering from tuberculosis left behind through lack of child-adapted treatments.


Create the market for child-adapted TB medicines by increasing number of manufacturers; respond to new WHO guidelines which recommend higher dosages for children.


  • Over 1.2 million curative and preventive treatments provided for children.
  • UNITAID provides funding to TB Alliance to facilitate the development of child-adapted medicines that meet new WHO guidelines for treating children with TB.



UNITAID brought the first-ever quality paediatric TB medicines to market and is one of the largest providers of quality child-friendly TB medicines.